ARCHIVES

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan

June 10, 1988

In Brief: NIEHS to Observe20th Anniversary Dec. 3-5 With Scientific Presentations, Big Celebration

November 21, 1986

Flood Says Congress Will Renew Cancer Act, But Only After “All Out” Review of Research Policy

December 3, 1976

Reimbursement Policy By Philadelphia Blue Cross Further Explained

April 21, 1989

Three cancer societies to be led by Vanderbilt faculty in 2004

July 18, 2003

In the States: Georgia Requires Coverage Of Routine Costs For Children In Clinical Trials

August 14, 1998